Ovarian Cancer Metabolic Signature May Be Targeted to Prevent Disease Progression

Ovarian Cancer Metabolic Signature May Be Targeted to Prevent Disease Progression
A metabolic signature pathway critical for the growth of cancer stem cells has been identified by researchers who believe it may be cancer’s Achilles heel, and that interfering with it may halt the growth of ovarian cancer. Findings were published online in Cell Stem Cell in the study “Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *